Doses

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Condition:   Bronchial AsthmaInterventions:   Drug: Intravenous magnesium sulfate;   Drug: Inhaled budesonide;   Drug: normal salineSponsor:   Hamad Medical CorporationRecruiting – verified May 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days




Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses” in Healthy Volunteers.

Condition:   AsthmaInterventions:   Drug: PBF-680;   Drug: PlaceboSponsors:   Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau;   Palo Biofarma, S.LRecruiting – verified August 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days




Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma

Condition:   AsthmaInterventions:   Drug: Indacaterol 27.5 mcg;   Drug: Indacaterol 37.5;   Drug: Indacaterol 55 mcg;   Drug: Indacaterol 75 mcg;   Drug: Indacaterol 150 mcg;   Drug: PlaceboSponsors:   Novartis;   Novartis PharmaceuticalsNot yet recruiting – verified October 2013 View full post on ClinicalTrials.gov: asthma | received in the last 14 days